Published in
Elsevier, Lancet Global Health, 2(12), p. e257-e270, 2024
DOI: 10.1016/s2214-109x(23)00522-3
Links
Tools
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
Journal article published in 2024 by
Vianney Tricou 
,
Delia Yu,
Humberto Reynales,
Shibadas Biswal,
Xavier Saez-Llorens,
Chukiat Sirivichayakul,
Pio Lopez,
Charissa Borja-Tabora,
Lulu Bravo,
Pope Kosalaraksa,
Luis Martinez Vargas,
Maria Theresa Alera,
Luis Rivera,
Veerachai Watanaveeradej,
Reynaldo Dietze
and other authors.
,
Delia Yu,
Humberto Reynales,
Shibadas Biswal,
Xavier Saez-Llorens,
Chukiat Sirivichayakul,
Pio Lopez,
Charissa Borja-Tabora,
Lulu Bravo,
Pope Kosalaraksa,
Luis Martinez Vargas,
Maria Theresa Alera,
Luis Rivera,
Veerachai Watanaveeradej,
Reynaldo Dietze
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 